MAA
ANIP icon

Managed Account Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Managed Account Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$2.78M Buy
44,794
+7,123
+19% +$424K ﹤0.01% 1701
2015
Q1 		$2.36M Buy
37,671
+6,746
+22% +$410K ﹤0.01% 1769
2014
Q4 		$1.74M Buy
+30,925
New +$1.36M ﹤0.01% 1872

Other funds holding ANIP

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
TCM
Timpani Capital Management Milwaukee, Wisconsin $209M AUM 62.15% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Managed Account Advisors's ANIP Position: Q2 2015 in Review

Managed Account Advisors increased its ANI Pharmaceuticals (ANIP) stake by 19% in Q2 2015, buying an estimated $424K and bringing the position to 44,794 shares worth $2.78M. The position accounts for ﹤0.01% of the portfolio, ranked #1701.

Managed Account Advisors first reported a position in ANIP in Q4 2014 and has held it in 3 quarters since. 123 funds tracked by Wall St. Rank hold ANIP as of Q2 2015.

  • Managed Account Advisors held 44,794 shares of ANI Pharmaceuticals worth $2.78M as of Q2 2015.
  • Managed Account Advisors bought 7,123 ANI Pharmaceuticals shares in Q2 2015, an estimated $424K.
  • ANI Pharmaceuticals made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #1701 holding.
  • Managed Account Advisors first reported a position in ANI Pharmaceuticals in Q4 2014 and has held it in 3 quarters since.
  • 123 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.